We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information and sources of further guidance relating to the current shortage of products used in the treatment of some bladder cancers
Following a public consultation and the review of a reclassification application from the manufacturer, the MHRA has decided that Aquiette 2.5mg Tablets will remain a prescription-only medicine.
This document contains a synopsis of causation occurring in cancer of the bladder.
This is the council’s note about bladder cancer and mineral oils.
This is the council’s note about the risk of bladder cancer in pre-bake aluminium smelters.
A review of the risk of bladder cancer in hairdressers, barbers and textile workers.
Public consultation on a set of proposals to make Aquiette 2.5mg Tablets (oxybutynin hydrochloride) available from pharmacies
Projects granted during 2015 that have a primary purpose of translational and applied research: human urogenital and reproductive disorders.
List of Field Safety Notices from 22 to 26 April 2024.
This is the council's note about lung and bladder cancer and diesel exhaust emissions.
Projects granted during 2016 that have a primary purpose of translational research - human urogenital/reproductive disorders.
The characteristics, diagnosis, management, surveillance and epidemiology of Escherichia coli (E. coli).
The Medicines and Healthcare products Regulatory Agency is calling for women who experience symptoms associated with overactive bladder such as the urgent need to urinate to make their views heard as part of a consultation launched today.
Projects granted during 2014 that have a primary purpose of translational and applied research: human cancer.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.